2025 Annual Seminar Schedule at a Glance

*Seminar Schedule Subject to Change.
Friday Schedule
Saturday Schedule
Sunday Schedule

Friday, April 25, 2025

12:00 - 6:00 pm
Registration Opens

12:30 – 2:00 pm
Past Presidents Luncheon

1:00 – 2:00 pm (General Session)
Aligning purpose and meaning in work to address burnout 
Presented by Susan Morley
Burnout, an occupational syndrome occurring when job demands exceed job resources, has devastating consequents for health care professionals, trainees, patients, and the performance of the institution. We will examine how the nature of work has changed and consider strategies managers and organizations can use to promote employee engagement.

2:05 - 3:05 pm (General Session) 
SGLT-2 Inhibitors and Beyond: The Latest in CKD Drug Advances
Presented by Kathy Sentena & Megan Herink
Evidence for the use of SGLT-2 inhibitors and other treatments in patients with chronic kidney disease (CKD) will be presented. Key clinical trials of renal and cardiovascular benefits leading to expanded indications for SGLT-2 inhibitors will be discussed. Clinical implications, including patient-specific considerations, of implementing therapies for CKD will be highlighted.

3:10 - 4:10 pm (General Session) 
AI and Digital Health in Pharmacy Practice

Presented by Stacey Olstad
The presentation "AI and Digital Health in Pharmacy Practice" by Stacey Olstad discusses the transformative impact of AI and digital health technologies on healthcare, particularly in pharmacy practice. It highlights the importance of pharmacists being able to evaluate the accuracy and usefulness of these technologies. The presentation covers various digital health tools, including electronic health records, telemedicine, wearable devices, and AI applications. It also addresses ethical considerations, the need for model evaluation, and the integration of AI into clinical workflows.

4:15 – 5:15 pm
Addressing Interrelated Cardio-Renal-Metabolic Conditions to Improve Population Health
Presented by Candis Morello
Addressing interrelated cardio-renal-metabolic (CRM) conditions is crucial for improving population health due to their growing burden on individuals and healthcare systems. The complexity of managing these interconnected conditions increases healthcare costs, as patients require more interventions and specialized care. Evidence-based strategies, including integrated care models, patient education, and multidisciplinary teams, can improve outcomes and reduce costs. One health system, for example, improved care coordination and reduced readmissions by implementing a communication model among specialists and primary care providers through shared electronic health records and dedicated care coordinators, leading to more efficient care delivery.

5:30 - 7:00 pm
Welcome Reception with Exhibitors

7:00 pm
OSU Alumni Reception

Saturday, April 26, 2025

7:00 am – 5:30 pm
Registration Open

7:00 - 8:00 am
Gary Clausen Memorial 2-mile Run/Walk (optional)
We challenge you to dig out your running shoes and headbands and wake up with us with a short run (or walk)!  This free event is for all OSHP Annual Seminar attendees and honors Gary Lee Clausen, a former OSHP President and avid runner who repeatedly won this annual event. Prizes will be awarded to the top male and female finishers (but don’t let that keep you from running)! Start your Saturday morning off right and get energized for a fun-filled day of learning and networking *Please indicate by name above if any are under the age of 13 years. Pre-registration is required.

8:00 - 8:30 am
Continental Breakfast with Exhibits

8:30 - 9:30 am
Equitable Care: The Pharmacist's Impact on Health Disparities

Presented by Kristy Butler, Marie Chisholm-Burns, and Yvonne Rice
The presentation and panel discussion will advance understanding of the role of pharmacists in health equity. To this end, we will discuss the social determinants of health (SDOH), their impact on health disparities, and barriers to their integration in healthcare systems. We will also consider how health disparities affect patient outcomes and quality of life, and share opportunities for interventions and practices to promote health equity.

9:30 - 9:45 am
Break with Exhibitors

9:45 - 10:45 am (General Session)
Menopause is Having a Moment
Presented by Lorinda Anderson 
More than half of the population will experience menopause, and 40% of their life happens after menopause. The onset of menopause (a.k.a. perimenopause) is marked by symptoms that are brought on by the decrease in estrogen levels, and that can be relieved with hormone replacement therapy (HRT). However, after the results of the Women’s Health Initiative were published more than 20 years ago, it is still very difficult for women to get treatment; even when most would be appropriate to receive treatment with HRT. This has correlated with an increase in misinformation and unproven treatments that pharmacy professionals should be aware of and know how to guide patients to proven treatments that may actually benefit them beyond treating symptoms.

10:45 am - 12:00 pm
Exhibits Open in the Great Hall

10:45 am - 12:00 pm
Job Fair

12:00 - 1:00 pm
Lunch

1:00 - 2:00 pm
OSHP Section Networking

Meet and network with colleagues who share your professional interests. Sections include  Ambulatory Care, Management, Informatics/Technology/Research, Inpatient Practitioners/Clinical Specialists.

1:00 - 2:00 pm
Poster Session
Network with colleagues, learn about practice changes and share results of new initiatives during the judged poster display. Prizes are offered for students and resident/practitioner categories – stop by and support the efforts. 

2:00 - 3:00 pm (Track A)
Buprenorphine for Chronic Pain: Clinical Pearls
Presented by Spencer Potter
This presentation outlines the various different formulations of buprenorphine, focusing on those used for chronic pain management. Information regarding appropriate dosing, administration, monitoring, and patient counseling points will be covered. It also explores real-world scenarios and common drug information questions surrounding buprenorphine's use for chronic pain in outpatient care settings.

2:00 - 3:00 pm (Track B) 
T-cell Engager Therapies: Considerations for Implementation and Management
Presented by Jack Rasmussen
The recent surge in FDA approvals for T-cell engager (TCE) therapies has provided both opportunity and challenge to cancer centers across the United States. This talk will review the safe and effective use of TCE therapy, future directions of TCEs, and considerations for administration in clinics.

3:05 - 4:05 (Track A)
Acute Pain Management in Patients with an Opioid Use Disorder
Presented by Emily Skogrand
Opioid use disorder complicates successful acute pain management in hospitalized patients. This lecture will describe pain management strategies to manage acute pain while recognizing the need to concurrently treat acute opioid withdrawal and opioid use disorder.

3:05 - 4:05 (Track B)
A Field Guide to Transplant and Transplant ID Management for the Generalist
Presented by YoungYoon Ham & Danielle Boschetto
Transplant and ID team up to tackle some of the most common issues (that we've been asked about and others that we just wanted to talk about but have never actually been asked) that come up when dealing with transplant patient. Transplant recipients may experience a variety of complications, related and unrelated to transplant, for which they require hospitalization. In this presentation we aim to address how best to approach a transplant patient, before and after transplant, and provide guidance on how their care may differ from that of the general population.

4:10 - 5:10 pm (Track A)
Keep Patients Safer with an Opioid Taper
Presented by Mindee Dewitt & Darlene Marsh
The benefits and risks of chronic opioid therapy should be regularly reevaluated, and tapering should be considered when appropriate. Pharmacists are in a unique position to provide safety education, opioid taper recommendations, and additional support to clinicians to promote patient success in tapering down or off prescription opioids. This session will focus on when to recommend an opioid taper, how to manage opioid withdrawal and strategies to support both clinicians and patients on maximizing safer opioid prescribing and pain management strategies.

4:10 - 5:10 pm (Track B)
Optimizing Strategies and Approaches for Treatment-Resistant Depression

Presented by Marketa Marvanova
Treatment-resistant depression (TRD) remains a significant challenge in clinical practice, affecting approximately 30% of patients with major depressive disorder (MDD). While there is no single universally accepted definition of TRD, the most commonly used and FDA-accepted definition describes it as MDD that does not achieve an adequate response despite at least two trials of antidepressants from different classes, administered at the appropriate dose and duration. Many patients with TRD struggle to achieve full remission despite multiple therapeutic trials, leading to a substantial burden on quality of life, increased healthcare costs, and heightened suicide risk. This session aims to equip attendees with a comprehensive understanding of TRD, identify and address factors contributing to pseudoresistance in depression treatment, overcome common barriers to effective therapy, and explore evidence-based pharmacologic and non-pharmacologic strategies and approaches to optimize treatment and support the management of TRD.

6:00 – 8:00 pm
Awards Celebration Banquet
Doors open at 6:00 pm | Dinner served at 6:30 pm


Get groovy with us at the 70’s Theme Awards Dinner during the Annual Seminar! Join us on April 26, 2025, at 6:00 PM for a night of funky, fresh, and fabulous fun. Dress in your best disco vibes and get ready to boogie!

 

 

 

Sunday, April 27, 2025

7:00 am – 12:30 pm
Registration Open

7:00 - 8:30 am
Continental Breakfast 

8:00 - 9:00 am
Chronic Disease Management for Older Adults
Presented by Danielle Backus and John Begert
Implement strategies to reduce medication administration burden for commonly prescribed medications, identify relevant drug-drug and drug-disease interactions and formulate pharmacotherapy assessments and plans for older adults.

9:05 - 10:05 am
Clinical Pearls

 

  • SGLT2 inhibitors and risk of genitourinary tract infections - Presented by Katherine O. Marks, PharmD
  • International travel: Pharmacist Role in Ensuring Patients Arrive with Their Medications - Presented by Hanna, M Kirwan, PharmD Resident
  • Practical tools for addressing medication nonadherence in clinical practice - Presented by Madeline Tyler
  • Induction of buprenorphine using micro-dosing strategy - Presented by Duong, Phuong, Y PharmD, BCPS 

 

10:10- 11:10 am
Mapping Cause Analysis: Who, What, How, and Why
Presented by Katie Hufft
After a medication error occurs, we commonly hear the questions ‘how did this happen’ and ‘what can we do to prevent this from happening again.’ Knowing how to answer these questions is essential to reducing risk for future error. This Medication Safety presentation will provide a road map to the immediate next steps after a medication error occurs. This will include an overview of cause analysis, which is a methodical process used to identify systemic risks that contribute to safety events. We will breakdown the elements of a causal statement, identify several tools used to uncover root causes, and demonstrate how cause analysis can inform action planning to improve medication safety.

11:15 am - 12:15 pm
Oregon Board of Pharmacy - Law Update
Presented by Gary Runyon
The Board of Pharmacy will provide a timely update on recent and prospective changes to legislation and rules that may impact the practice of pharmacy, in addition to addressing emerging compliance trends.

12:15 pm
Annual Seminar Concludes